FDA Inspection
USpharma, Ltd., Co.USpharma, Ltd., Co. – FDA Inspection, Sep 3, 2026
Record Details
This FDA Inspection record concerns USpharma, Ltd., Co., with an inspection on September 3, 2026, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · f42c646f-2e75-441f-adb7-44400bb75e06
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1334262
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of USpharma, Ltd., Co.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2026 | Not classified | Florida District Office | |
| May 11, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 16, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for USpharma, Ltd., Co.
- FDA Inspection 1334958 - 2026-09-01
- FDA Inspection 1205546 - 2023-05-11
- FDA Inspection 1198249 - 2023-02-16
- FDA Inspection 1172561 - 2022-06-23
- FDA Inspection 912614 - 2015-02-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.